Benzinga | Aug 13, 2020 04:35PM EDT

VistaGen Therapeutics Q1 EPS $(0.07) Up From $(0.15) YoY

VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly losses of $(0.07) per share. This is a 53.33 percent increase over losses of $(0.15) per share from the same period last year.